On Monday, Newmark Group earned an upgrade to its Relative Strength (RS) Rating, from 68 to 73.
IBD's proprietary rating tracks share price movement with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of their moves. See if Newmark Group can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Newmark Group is now considered extended and out of buy range after clearing an 11.51 buy point in a first-stage consolidation. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
The company showed 22% EPS growth in its most recent report. Revenue gains came in at 11%.
Newmark Group holds the No. 9 rank among its peers in the Real Estate-Development/Operations industry group. Amrep Corp, CBRE Group and Jones Lang LaSalle are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
